{
    "id": 9883,
    "title": "Bekendtgørelse om krav til udformning af bivirkningsindberetninger og periodiske sikkerhedsopdateringer m.v.",
    "documentTypeId": "60",
    "isSagsforlobPeriodValid": true,
    "shortName": "BEK nr 262 af 19/04/2004",
    "documentHtml": "<div class=\"bjelke\">Oversigt (indholdsfortegnelse)</div><DIV CLASS=PARA ID=\"OVERSIGT\"> \r\n\r\n\r\n\r\n<UL>  \r\n\r\n</UL>  \r\n\r\n</UL>  \r\n\r\n</UL>  \r\n\r\n<table border=\"0\"><tr><td valign=\"top\" width=\"130\"><A HREF=\"#B1\">Bilag  \r\n\r\n 1</A></td><td></td></table>  \r\n\r\n</DIV><div class=\"bjelke\">Den fulde tekst</div><DIV CLASS=PARA ID=\"INDHOLD\"> \r\n\r\n\r\n<P ALIGN=\"CENTER\" class=\"Titel\" style=\"font-size:16 pt\">  \r\n\r\n Bekendtgørelse om krav til udformning af  \r\n\r\n<BR>  \r\n\r\n bivirkningsindberetninger og periodiske  \r\n\r\n<BR>  \r\n\r\n sikkerhedsopdateringer m.v.  \r\n\r\n</P>  \r\n\r\n<P class=\"lsp8L\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n<P class=\"Indledning2\">  \r\n\r\n I medfør af §&nbsp;9 og §&nbsp;13, stk.&nbsp;3, i  \r\n\r\n bekendtgørelse nr. 567 af 28. juni 2002 om bivirkningsovervågning af  \r\n\r\n lægemidler  \r\n\r\n fastsættes:  \r\n\r\n</P>  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P1\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;1.  \r\n\r\n</B>  \r\n\r\n Denne bekendtgørelse fastlægger krav til udformningen af indberetninger af  \r\n\r\n bivirkninger, eksponeringsreaktioner og periodiske sikkerhedsopdateringer  \r\n\r\n (PSUR), som indehaveren af markedsføringstilladelsen til et lægemiddel skal  \r\n\r\n indsende til Lægemiddelstyrelsen, kompetente myndigheder i andre EU/EØS-lande  \r\n\r\n og/eller Det Europæiske Agentur for Lægemiddelvurdering efter bestemmelserne  \r\n\r\n i  \r\n\r\n §§&nbsp;6-8 i bekendtgørelse om bivirkningsovervågning af lægemidler.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;2.  \r\n\r\n</I>  \r\n\r\n Denne  \r\n\r\n bekendtgørelse fastsætter endvidere krav til Lægemiddelstyrelsen og  \r\n\r\n indehaveren  \r\n\r\n af markedsføringstilladelsen om, at indberetninger af bivirkninger fremkaldt  \r\n\r\n af  \r\n\r\n lægemidler til human brug fremsendes og modtages elektronisk.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 1\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P2\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;2.  \r\n\r\n</B>  \r\n\r\n Indberetning af bivirkninger fremkaldt af lægemidler til human brug i henhold  \r\n\r\n til §§&nbsp;6 og 7 i bekendtgørelse om bivirkningsovervågning af lægemidler  \r\n\r\n skal foretages elektronisk som anført i bilag 1.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;2.  \r\n\r\n</I>  \r\n\r\n Lægemiddelstyrelsen fremsender indberetninger elektronisk om formodede  \r\n\r\n alvorlige bivirkninger fremkaldt af lægemidler til human brug set i Danmark  \r\n\r\n via  \r\n\r\n Det Europæiske Agentur for Lægemiddelvurderings EudraVigilance Gateway.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;3.  \r\n\r\n</I>  \r\n\r\n Indehaveren  \r\n\r\n af markedsføringstilladelsen skal modtage indberetninger, der er nævnt i  \r\n\r\n stk.&nbsp;2, via Det Europæiske Agentur for Lægemiddelvurderings  \r\n\r\n EudraVigilance  \r\n\r\n Gateway.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;4.  \r\n\r\n</I>  \r\n\r\n Indehaveren  \r\n\r\n af markedsføringstilladelsen skal oplyse sin profil på Det Europæiske Agentur  \r\n\r\n for Lægemiddelvurderings EudraVigilance Gateway til Lægemiddelstyrelsen.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 2\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P3\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;3.  \r\n\r\n</B>  \r\n\r\n Indberetning af bivirkninger eller eksponeringsreaktioner fremkaldt af  \r\n\r\n lægemidler til veterinær brug i henhold til §§&nbsp;6 og 7 i bekendtgørelse  \r\n\r\n om  \r\n\r\n bivirkningsovervågning af lægemidler skal ske på et særligt skema (European  \r\n\r\n Veterinary Pharmacovigilance Reporting Form for Marketing Authorisation  \r\n\r\n Holders), der fås ved henvendelse til Lægemiddelstyrelsen. Skemaet skal  \r\n\r\n underskrives og indsendes til den kompetente myndighed.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 3\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P4\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;4.  \r\n\r\n</B>  \r\n\r\n En  \r\n\r\n periodisk sikkerhedsopdatering, jf. §&nbsp;8 i bekendtgørelse om  \r\n\r\n bivirkningsovervågning af lægemidler, skal indeholde følgende:  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 1)  \r\n\r\n &#9;  \r\n\r\n en kort beskrivelse  \r\n\r\n af lægemidlet og eventuelle tidligere sikkerhedsopdateringer,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 2)  \r\n\r\n &#9;  \r\n\r\n en verdensomspændende  \r\n\r\n oversigt over lægemidlets markedsføringstilladelser fra udstedelsen af  \r\n\r\n markedsføringstilladelsen til og med perioden for den aktuelle  \r\n\r\n sikkerhedsopdatering,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 3)  \r\n\r\n &#9;  \r\n\r\n en oversigt over de  \r\n\r\n sikkerhedsmæssige initiativer Lægemiddelstyrelsen, kompetente myndigheder  \r\n\r\n eller  \r\n\r\n indehaveren af markedsføringstilladelsen måtte have iværksat siden  \r\n\r\n indsendelsen  \r\n\r\n af forrige sikkerhedsopdatering eller siden udstedelsen af  \r\n\r\n markedsføringstilladelsen  \r\n\r\n (den aktuelle periode),  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 4)  \r\n\r\n &#9;  \r\n\r\n lægemidlets godkendte  \r\n\r\n produktresumé og en beskrivelse af de ændringer, som enten måtte være  \r\n\r\n foretaget  \r\n\r\n heri i den aktuelle periode eller er planlagt,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 5)  \r\n\r\n &#9;  \r\n\r\n et begrundet skøn  \r\n\r\n over antallet af patienter eller dyr inddelt på dyreart behandlet med  \r\n\r\n lægemidlet i den aktuelle periode,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 6)  \r\n\r\n &#9;  \r\n\r\n en fortegnelse over  \r\n\r\n og gennemgang af alle formodede bivirkninger og eksponeringsreaktioner  \r\n\r\n registreret i den aktuelle periode, jf. §&nbsp;5 i bekendtgørelse om  \r\n\r\n bivirkningsovervågning af lægemidler, herunder:  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n a)  \r\n\r\n &#9;  \r\n\r\n alle alvorlige og ikke  \r\n\r\n alvorlige formodede bivirkninger,  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n b)  \r\n\r\n &#9;  \r\n\r\n indberetninger fra  \r\n\r\n patienter og pårørende,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 7)  \r\n\r\n &#9;  \r\n\r\n en præsentation af  \r\n\r\n gennemførte eller planlagte sikkerhedsundersøgelser og relevant videnskabelig  \r\n\r\n litteratur offentliggjort i den aktuelle periode,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 8)  \r\n\r\n &#9;  \r\n\r\n en videnskabelig  \r\n\r\n vurdering af fordele og ulemper ved lægemidlet i form af :  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n a)  \r\n\r\n &#9;  \r\n\r\n en evaluering af  \r\n\r\n sikkerhedsdata for den aktuelle periode set i relation til produktresumeet,  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n b)  \r\n\r\n &#9;  \r\n\r\n en overordnet  \r\n\r\n vurdering af lægemidlets sikkerhedsprofil,  \r\n\r\n</P>  \r\n\r\n<P class=\"Nummer\">  \r\n\r\n 9)  \r\n\r\n &#9;  \r\n\r\n en konklusion i form  \r\n\r\n af:  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n a)  \r\n\r\n &#9;  \r\n\r\n angivelse af  \r\n\r\n sikkerhedsdata, der ikke er i overensstemmelse med de hidtidige kumulerede  \r\n\r\n erfaringer og  \r\n\r\n</P>  \r\n\r\n<P class=\"Litra\">  \r\n\r\n b)  \r\n\r\n &#9;  \r\n\r\n forslag til  \r\n\r\n eventuelle nye sikkerhedsmæssige initiativer.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;2.  \r\n\r\n</I>  \r\n\r\n Indehaveren  \r\n\r\n af markedsføringstilladelse til parallelimport af et lægemiddel, jf. kapitel  \r\n\r\n 3  \r\n\r\n i bekendtgørelse nr. 165 af 13. marts 1995, om markedsføringstilladelse til  \r\n\r\n lægemidler, er ikke omfattet af stk.&nbsp;1.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 4\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P5\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;5.  \r\n\r\n</B>  \r\n\r\n Med  \r\n\r\n bøde straffes den, der overtræder §&nbsp;2, stk.&nbsp;1, 3 og 4 og §§&nbsp;3  \r\n\r\n og  \r\n\r\n 4.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;2.  \r\n\r\n</I>  \r\n\r\n Der kan  \r\n\r\n pålægges selskaber m.v. (juridiske personer) strafansvar efter reglerne i  \r\n\r\n straffelovens 5. kapitel.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 5\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P6\">  \r\n\r\n<P class=\"Paragraftekst\"> <B> §&nbsp;6.  \r\n\r\n</B>  \r\n\r\n Bekendtgørelsen træder i kraft den 28. april 2004.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n<I>  \r\n\r\n Stk.&nbsp;2.  \r\n\r\n</I>  \r\n\r\n Bestemmelserne i §&nbsp;2 træder i kraft den 1. januar 2005.  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"§ 6\" -->  \r\n\r\n<DIV CLASS=GIVET ID=\"GIVET\">  \r\n\r\n<FONT SIZE=\"3\">  \r\n\r\n<P CLASS=GIVET ALIGN=\"CENTER\"><I>Lægemiddelstyrelsen, den 19. april  \r\n\r\n 2004</I></P>  \r\n\r\n<P CLASS=SIGN1 ALIGN=\"CENTER\">Jytte Lyngvig</P>  \r\n\r\n<P CLASS=SIGN2 ALIGN=\"RIGHT\">/Finn H. Clemmensen</P>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"GIVET\" -->  \r\n\r\n<A NAME=\"\"B1\"\"></A>\r\n\r\n<DIV CLASS=BILAG ID=\"B1\">  \r\n\r\n<BR>  \r\n\r\n<HR width=70% align=center>  \r\n\r\n<P class=\"Bilagstitel\">Bilag 1 </P>  \r\n\r\n<P class=\"BilagsOverskrift\"> Beskrivelse af de oplysninger, der skal anføres  \r\n\r\n ved elektronisk indberetning af bivirkninger fremkaldt af lægemidler til  \r\n\r\n human brug, jf. §&nbsp;2. </P>  \r\n\r\n<P class=\"TekstoverskriftVB\">  \r\n\r\n 1. Grundlæggende dataformat  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n Indberetningen af oplysninger skal ske elektronisk i formatet ICH  \r\n\r\n E2B(M) som specificeret i ICH ICSR DTD version 2.1. Der skal anvendes XML.  \r\n\r\n Oplysninger om ICH E2B(M) og ICH ICSR DTD version 2.1 forefindes på  \r\n\r\n www.eudravigilance.org.  \r\n\r\n</P>  \r\n\r\n<P class=\"TekstoverskriftVB\">  \r\n\r\n 2. Transmissionskanal  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n Indberetninger foretages via Det Europæiske Agentur for  \r\n\r\n Lægemiddelvurderings EudraVigilance Gateway.  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n Lægemiddelstyrelsens profil på EudraVigilance Gateway er  \r\n\r\n DKMAEUDRA.  \r\n\r\n</P>  \r\n\r\n<P class=\"TekstoverskriftVB\">  \r\n\r\n 3. Indhold af indberetninger  \r\n\r\n</P>  \r\n\r\n<P class=\"Stk\">  \r\n\r\n Al relevant information vedrørende bivirkningen indberettes som  \r\n\r\n specificeret i standarden ICH E2B(M). Som minimum skal en elektronisk  \r\n\r\n bivirkningsindberetning dog indeholde følgende oplysninger, hvor de nævnte  \r\n\r\n numre henviser til ICH E2B(M):  \r\n\r\n</P>  \r\n\r\n<TABLE class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\"  \r\n\r\n style='border-collapse:collapse;mso-table-layout-alt:fixed;border:none;mso  \r\n\r\n -border-alt:solid windowtext .75pt;mso-padding-alt:0cm 3.5pt 0cm  \r\n\r\n 3.5pt;mso-border-insideh:.75pt solid windowtext;mso-border-insidev:.75pt  \r\n\r\n solid windowtext'>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\"  \r\n\r\n style='width:12.0cm;border:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.1 Dato for  \r\n\r\n sidste opdatering  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.1.7b  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Modtagelsesdato for den nyeste information i rapporten  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.2 Rapportnummer  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.1.10.1  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n En myndigheds rapportnummer  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.1.10.2  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Anden afsenders rapportnummer  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.3 Indberetter  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.1.1d  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Indberetters efternavn  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.1.2a  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Indberetters virksomhed  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.1.2f  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Indberetters postnummer  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.1.3  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Indberetters landekode i henhold til ISO 3166  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.1.4  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Indberetter type  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.2  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Litteratur reference  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.2.3.1  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Navn på klinisk forsøg  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.4 Afsender  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n A.3.1.2  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Afsenders virksomhed  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.5 Patient  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.1  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Patientens initialer  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.1.1a  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Journalnummer i almen praksis  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.1.1b  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Journalnummer hos specialist  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.1.1c  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Journalnummer på hospital  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.1.1d  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Journalnummer i klinisk forsøg  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.2.1b  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Patientens fødselsdato  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.2.2a og B.1.2.2b  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Patientens alder ved bivirkningens indtræden og enhed for  \r\n\r\n alder  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.2.3  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Patientens aldersgruppe  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.1.5  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Patientens køn  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.6 Bivirkning  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:solid windowtext  \r\n\r\n 1.0pt;border-bottom:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.2.i.1a og B.2.i.1b  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border:none;border-right:solid windowtext  \r\n\r\n 1.0pt;mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid  \r\n\r\n windowtext .75pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-right-alt:solid  \r\n\r\n windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n MedDRA version og bivirkningsdiagnose angivet i MedDRA  \r\n\r\n kode  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:none;border-right:solid  \r\n\r\n windowtext 1.0pt;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-left-alt:solid windowtext .75pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-right-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='page-break-inside:avoid'>  \r\n\r\n<TD width=\"454\" colspan=\"2\" valign=\"top\" style='width:12.0cm;border-top:solid  \r\n\r\n windowtext 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n &nbsp;  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n<B>  \r\n\r\n 3.7 Lægemiddel  \r\n\r\n</B>  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border-top:solid windowtext  \r\n\r\n 1.0pt;border-left:none;border-bottom:solid windowtext  \r\n\r\n 1.0pt;border-right:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-bottom-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm  \r\n\r\n 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.4.k.2.1  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Lægemiddelnavn  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n ELLER  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR style='mso-yfti-lastrow:yes'>  \r\n\r\n<TD width=\"76\" valign=\"top\" style='width:2.0cm;border:solid windowtext  \r\n\r\n 1.0pt;border-top:none;mso-border-top-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n B.4.k.2.2  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"378\" valign=\"top\"  \r\n\r\n style='width:10.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n Aktivt lægemiddelstof på engelsk  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n<TD width=\"76\" valign=\"top\"  \r\n\r\n style='width:2.0cm;border-top:none;border-left:none;border-bottom:solid  \r\n\r\n windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt:solid  \r\n\r\n windowtext .75pt;mso-border-left-alt:solid windowtext  \r\n\r\n .75pt;mso-border-alt:solid windowtext .75pt;padding:0cm 3.5pt 0cm 3.5pt'>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<P class=\"TabelTekst\">  \r\n\r\n &nbsp;  \r\n\r\n</P>  \r\n\r\n</DIV><!-- End of \"Bilag 1 \" -->  \r\n\r\n</DIV>",
    "isHistorical": true,
    "editorialNotes": [],
    "alternativeMedia": [],
    "ressort": "Indenrigs- og Sundhedsministeriet",
    "isReprint": false,
    "geografiskDaekningId": 0,
    "retsinfoKlassifikationId": 10,
    "caseHistoryReferenceGroup": [],
    "metadata": [
        {
            "displayName": "Offentliggørelsesdato",
            "displayValue": "27/04/2004"
        },
        {
            "displayName": "Accession",
            "displayValue": "B20040026205"
        },
        {
            "displayName": "Entydig dokumentidentifikation",
            "displayValue": "AI001605"
        },
        {
            "displayName": "Dato for førstegangsindlæggelse",
            "displayValue": "27/04/2004"
        },
        {
            "displayName": "Dato for indlæggelse",
            "displayValue": "24/08/2006"
        },
        {
            "displayName": "Dokumenttype",
            "displayValue": "Bekendtgørelse"
        },
        {
            "displayName": "Dokumentets rangering",
            "displayValue": "B "
        },
        {
            "displayName": "Forskriftens nummer",
            "displayValue": "262"
        },
        {
            "displayName": "År for udstedelse",
            "displayValue": "2004"
        },
        {
            "displayName": "Dato for underskrift",
            "displayValue": "19/04/2004"
        },
        {
            "displayName": "Offentliggjort i (publiceringsmedie)",
            "displayValue": "Lovtidende A"
        },
        {
            "displayName": "Administrerende myndighed",
            "displayValue": "Lægemiddelstyrelsen"
        },
        {
            "displayName": "Ressortministeriets journalnummer",
            "displayValue": "Indenrigs- og Sundhedsmin.,<br />Lægemiddelstyrelsen, j.nr."
        },
        {
            "displayName": "Stikord",
            "displayValue": "Bivirkningsindberetninger, periodiske sikkerhedsopdatering"
        }
    ],
    "pdfLink": {
        "isPdfAvailable": false
    },
    "documentFobTagGroup": [],
    "hasFobTags": false
}